Shares of Morepen Laboratories jumped over 8 per cent on Thursday after the company said its board has approved transfer of its medical devices business on a slump sale basis to a wholly-owned subsidiary.
The stock zoomed 8.28 per cent to close at ₹55.60 on the BSE. During the day, it jumped 10.90 per cent to ₹56.95. On the NSE, it rose by 8.38 per cent to close at ₹55.60. In traded volume terms, 6.72 lakh shares were traded at the BSE and over 49 lakh shares at the NSE. The revenues and profits derived from the new subsidiary will be consolidated in the parent company, it added. Transfer of the medical devices business is expected to be completed before March 31, 2022, it said.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.